The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.80
Bid: 50.20
Ask: 51.00
Change: 0.80 (1.60%)
Spread: 0.80 (1.594%)
Open: 51.00
High: 52.00
Low: 49.10
Prev. Close: 50.00
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Oct 2016 07:00

RNS Number : 3948M
Renold PLC
13 October 2016
 

Renold plc

("Renold", "the Company" or "the Group")

 

Period End Trading Update and Strategic Plan Progress

 

Renold, a leading international supplier of industrial chains and related power transmission products, is today issuing a period end trading update covering the six months ending 30 September 2016 (the 'Period') and an update on the Group's STEP 2020 Strategic Plan.

 

Period End Trading Update

 

Group revenue in the Period grew by 4.5% on a reporting basis, reflecting the benefit of the Group's significant non-sterling based operations. On an underlying(1) basis, Group revenue fell by 4.0% in the Period compared to the first half of the prior year. This was marginally ahead of previously announced expectations. Order intake in the Period grew by 9.2% on a reporting basis (or 0.2% on an underlying basis). The underlying Book to Bill(2) ratio in the Period was 101% (2015: 97%).

 

The Chain Division performed ahead of expectations in the Period by delivering growth in underlying revenue of 2.0% and underlying order intake of 4.8%. Both compare favourably to reductions seen in the immediately preceding half year (H2 2015: down 7.6% and 9.7% respectively). Revenue growth was driven by good European performance with modest growth also seen in Australasia, partly offset by continuing weakness in the Americas. The Chain underlying Book to Bill ratio was 99% (2015: 96%).

 

Markets for Torque Transmission were particularly challenging in the Period with falls in underlying sales of 22.9% and underlying order intake of 13.7%, both of which were similar to the immediately preceding half year (H2 2015: down 22.0% and 12.5% respectively). Approximately 5% of the fall in underlying sales was expected following the decision in the second half of the prior year to cease a low margin long term supply agreement with one customer. In addition, the marine and land based power generation markets were weak globally with commodity related industries also suffering in North America. As noted at the time of the AGM, order intake in the Period outstripped sales and hence the underlying Book to Bill ratio was 110% (2015: 97%).

 

The level of underlying sales activity and adjusted(3) operating profit in the Period has been in line with expectations and broadly similar to the second half of the previous year. However the impact of weaker sterling will boost reported results in the first half of the current year by approximately 10 per cent which will flow into the full year results. At this stage, it is too early to say the extent to which the beneficial currency impact will continue into the second half of the year. Our markets remain uncertain following the referendum vote and we do not have sufficient clarity on the final quarter of the year, traditionally the strongest, to be other than cautious about the longer term outlook.

 

STEP 2020 Strategic Plan

 

European Distribution Centre Employee Consultation Process

Subsequent to the previous announcement released on 1 September 2016, the Company has concluded the consultation process with its employees and their representatives at the European Distribution Centre near Lille in France. A project has now commenced to cease warehousing and distribution activities at the site. Our facility in Einbeck will consolidate the broader European warehousing and distribution activities with its own similar activities in Germany. The project is expected to complete during the third quarter of the current financial year with annualised savings of approximately £0.3m p.a. being delivered thereafter.

 

Sale of Freehold Property in France

Independently of the consultation process, the site near Lille had been marketed for sale since January 2015. The Group has now signed an agreement to sell its freehold interest in the site for its current book value of approximately £1.1m (€1.3m). This sale process is expected to complete in the next few months.

 

The Group's performance has allowed continued investment in both operating costs and capital spend to support delivery of the STEP 2020 Strategic Plan. Integration of the Tooth Chain acquisition continues to proceed well. International chain markets remain highly fragmented and management will continue to consider future acquisition opportunities which can support business growth.

 

There have been no other significant changes in the position of the Company over the period since the publication of the AGM Statement on 20 July 2016.

 

The Group expects to announce its Interim Results on 15th November 2016.

 

Notes:

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates by retranslating the prior year comparative figures to the current year exchange rate.

(2) The Book to Bill ratio is the ratio of order intake in the Period to sales in the Period.

(3) Adjusted items exclude exceptional items, the costs of administering closed defined benefit pension schemes, the amortisation of acquired intangibles and any associated tax thereon.

 

13 October 2016

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Arden Partners

020 7614 5917

Chris Hardie

Instinctif Partners

020 7457 2020

Mark Garraway

Helen Tarbet

 

 

 

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFEEIILFLIR
Date   Source Headline
12th Oct 20177:00 amRNSTrading Update
4th Oct 20173:11 pmRNSHolding(s) in Company
10th Aug 20175:16 pmRNSDirector Declaration
1st Aug 201711:37 amRNSBlock listing Interim Review
19th Jul 201712:29 pmRNSResult of AGM
19th Jul 20177:00 amRNSAGM Statement
14th Jul 201711:14 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSAnnual Report and Accounts
7th Jun 20172:26 pmRNSGrant of Awards - Performance Share Plan
2nd Jun 20174:40 pmRNSHolding(s) in Company
30th May 20177:00 amRNSFinal Results
4th May 201711:00 amRNSHolding(s) in Company
28th Apr 201710:39 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSNotification of Investor Visit
18th Apr 20171:21 pmRNSHolding(s) in Company
13th Apr 201710:35 amRNSHolding(s) in Company
11th Apr 20177:00 amRNSTrading Update
2nd Feb 20173:32 pmRNSBlock listing Interim Review
19th Jan 20173:08 pmRNSGrant of Awards - Performance Share Plan
9th Jan 20177:00 amRNSAppointment of Non-Executive Director
22nd Dec 20167:00 amRNSStrategic Update
23rd Nov 20161:48 pmRNSHolding(s) in Company
15th Nov 20167:00 amRNSHalf-year Report
13th Oct 201612:02 pmRNSPrice Monitoring Extension
13th Oct 20167:00 amRNSTrading Update
11th Oct 201612:07 pmRNSSecond Price Monitoring Extn
11th Oct 201612:02 pmRNSPrice Monitoring Extension
4th Oct 20162:28 pmRNSHolding(s) in Company
28th Sep 20167:45 amRNSHolding(s) in Company
16th Sep 20164:35 pmRNSPrice Monitoring Extension
6th Sep 20167:00 amRNSAppointment of new Finance Director
1st Sep 20167:00 amRNSUpdate on Strategic Plan
1st Aug 201611:31 amRNSBlock listing Interim Review
22nd Jul 20162:59 pmRNSEmployee Benefit Trust
21st Jul 20163:07 pmRNSGrant of Awards - Performance Share Plan
20th Jul 201611:33 amRNSResult of AGM
20th Jul 20167:01 amRNSDirectorate Change
20th Jul 20167:00 amRNSAGM Statement
17th Jun 20167:00 amRNSNotice of AGM
31st May 20167:00 amRNSRenold FY Results YE 31 March 2016
14th Apr 20169:00 amRNSNotice of Results
14th Apr 20167:00 amRNSTrading Update
12th Apr 20169:38 amRNSHolding(s) in Company
16th Feb 20169:08 amRNSHolding(s) in Company
12th Feb 201610:44 amRNSDirector/PDMR Shareholding
12th Feb 201610:21 amRNSHolding(s) in Company
12th Feb 201610:21 amRNSHolding(s) in Company
12th Feb 20169:42 amRNSHolding(s) in Company
11th Feb 201612:53 pmRNSDirector/PDMR Shareholding
11th Feb 20169:28 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.